These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8610646)

  • 1. A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Homesley HD; Look KY; McGehee R
    Am J Clin Oncol; 1996 Apr; 19(2):184-6. PubMed ID: 8610646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study.
    Jacobs AJ; Blessing JA; Munoz A
    Gynecol Oncol; 1992 Mar; 44(3):268-70. PubMed ID: 1541440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial.
    Weiss GR; Liu PY; O'Sullivan J; Alberts DS; Brown TD; Neefe JR; Hutchins LF
    Gynecol Oncol; 1992 Jun; 45(3):303-6. PubMed ID: 1535329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of Didemnin B (NSC #335319) in patients with previously treated epithelial ovarian cancer. A Gynecologic Oncology Group Study.
    Malfetano JH; Blessing JA; Jacobs AJ
    Am J Clin Oncol; 1993 Feb; 16(1):47-9. PubMed ID: 8424404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study.
    Weiss RB; Peterson BL; Allen SL; Browning SM; Duggan DB; Schiffer CA
    Invest New Drugs; 1994; 12(1):41-3. PubMed ID: 7960604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD; Hanjani P
    Invest New Drugs; 1991 Feb; 9(1):109-11. PubMed ID: 2026479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Malfetano JH; Blessing JA; Homesley HD
    Am J Clin Oncol; 1995 Dec; 18(6):495-7. PubMed ID: 8526192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Feun LG; Blessing JA; Barrett RJ; Hanjani P
    Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
    Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
    Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study.
    Kucuk O; Young ML; Habermann TM; Wolf BC; Jimeno J; Cassileth PA
    Am J Clin Oncol; 2000 Jun; 23(3):273-7. PubMed ID: 10857892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group.
    Sondak VK; Kopecky KJ; Liu PY; Fletcher WS; Harvey WH; Laufman LR
    Anticancer Drugs; 1994 Apr; 5(2):147-50. PubMed ID: 8049497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S; Blessing JA; McGehee R; Lentz SS
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group study.
    Taylor SA; Goodman P; Crawford ED; Stuckey WJ; Stephens RL; Gaynor ER
    Invest New Drugs; 1992 Apr; 10(1):55-6. PubMed ID: 1607254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.
    Rajdev L; Yu ZF; Wadler S; Weller E; Kahn SB; Tormey D; Skeel R; Wiernik PH
    Invest New Drugs; 2001; 19(3):233-7. PubMed ID: 11561680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319).
    Mittelman A; Chun HG; Puccio C; Coombe N; Lansen T; Ahmed T
    Invest New Drugs; 1999; 17(2):179-82. PubMed ID: 10638489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical study of didemnin B. A National Cancer Institute of Canada Clinical Trials Group study.
    Maroun JA; Stewart D; Verma S; Eisenhauer E
    Invest New Drugs; 1998; 16(1):51-6. PubMed ID: 9740544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.